Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspecs Group Regulatory News (SPEC)

Share Price Information for Inspecs Group (SPEC)

Share Price is delayed by 15 minutes
Get Live Data
97.00    0.00 (0.00%)
Bid:
94.00
Ask:
100.00
Spread: 6.00 (6.383%)
Market Cap: £105.90m
SPEC Live PriceLast checked at - London Stock Exchange

Intraday Inspecs Group Share Chart

Full Year Trading Update

1 Feb 2022 07:00

RNS Number : 2280A
Inspecs Group PLC
01 February 2022
 

1 February 2022

 

Inspecs Group plc

("Inspecs" or "the Group")

 

Full Year Trading Update

 

Inspecs Group plc, a leading designer, manufacturer and distributor of eyewear (sunglasses, optical frames and lenses) today announces a trading update for the year ended 31 December 2021 ahead of its final results in May 2022.

Highlights:

· Full year trading in line with Board expectations.

· Completed acquisitions of Swedish eyewear company EGO Eyewear Ltd and German distributor BoDe Design.

· Successful purchase of intellectual property including trademarks of Hardy Amies worldwide.

· New state of the art lens manufacturing facility in Gloucester nearing completion and production started end of December 2021.

 

The Group's trading performance for the year despite Covid-19 restrictions was in line with management's expectations delivering Group revenue of $241.0m (2020: $47.4m). The integration of the Group's Eschenbach acquisition in December 2020 is progressing to plan and the business delivered positive trading in 2021. The Group will continue to realise further synergies from the acquisition into 2022.

During the period, the Group completed the strategic acquisitions of Swedish eyewear company EGO Eyewear Ltd, along with its subsidiaries, and of German distributor BoDe Design. Both acquisitions will enhance the Group's brand portfolio and broadens the distribution of products around the world.

Our main markets in Europe and America have proved to be resilient, and early indications show that, despite restrictions in many of the countries in which we operate, the optical market remains open and current trading is in line with expectations for 2022.

· In Asia, our factories maintained production throughout most of the year, despite both supply chain and Covid-19 restrictions.

· Our new facility in Vietnam is now fully operational, and work has started on the design and planning for our third facility in Vietnam on our additional land purchased in 2021.

· The Group continues to work on its wider environmental and sustainability targets. Botaniq, our new sustainable collection manufactured from bio-based materials, has had a successful launch in 2021 and will continue to grow in 2022.

· The Group has won a number of design and green awards, including four red dot awards and the industry Green Award in 2021.

Inspecs trading outlook for 2022 remains positive with growth prospects underpinned by recent acquisitions and multiple opportunities to continue to grow the business across the globe. The management team remains confident that this strategy will continue to deliver sustained growth in 2022 and over the long-term.

 

Robin Totterman, Chief Executive Officer commented:

"The results achieved in 2021 follow on from the hard work our employees put in over the last 12-months and the implementation of our continuing strategy to build a fully integrated global eyewear business. The Group now has over 35 licensed and owned brands available to our customers around the world, and the ability to provide a sustainable one-stop-shop frame and lens package continues to gain momentum.

I remain confident about the Group's ability to continue to grow organically and through acquisition in the long-term and to continue to deliver further positive results for our customers, shareholders and all stakeholders."

 

For further information please contact:

 

Inspecs Group plc

Robin Totterman (CEO)

Chris Kay (CFO)

 

via FTI Consulting

Tel: +44 (0) 20 3727 1000

Peel Hunt (Nominated Adviser and Broker)

Adrian Trimmings

Andrew Clark

Lalit Bose

 

Tel: +44 (0) 20 7418 8900

FTI Consulting (Financial PR)

Alex Beagley

Alice Newlyn

Harriet Jackson

 

Tel: +44 (0) 20 3727 1000

 

About Inspecs Group plc

 

INSPECS is a Bath-based designer, manufacturer and distributor of eyewear frames and optically advanced spectacle lenses. The Group produces a broad range of frames and lenses, covering optical, sunglasses and safety, which are either "Branded" (either under licence or under the Group's own proprietary brands), or "OEM" (including private label on behalf of retail customers and un-branded).

INSPECS aims to be the leader in eyewear solutions through its vertically-integrated business model and has adopted a three pillar growth strategy to achieve this: (i) continue to grow organically; (ii) undertake further acquisitions (and drive value through leveraging the Group's internal capabilities); and (iii) extend the Group's manufacturing capacity.

 

The Group has completed a number of significant acquisitions since its IPO in February 2020. In December 2020, INSPECS acquired Eschenbach, a leading, global, eyewear supplier headquartered in Nuremberg, Germany, which includes the American company Tura. This followed the acquisition of lens maker Norville in July 2020, whereby INSPECS combined two heritage brands in British optical, Savile Row frame maker, and Norville lens maker, further enhancing its vertically integrated business model. In December 2021 the Group acquired Ego Eyewear, a design and licensing company which uses third party eyewear manufacturers to produce premium fashion brands, and BoDe, a distributor of optical and sunglasses frames principally to the German market.

 

INSPECS customers include global optical and non-optical retailers, global distributors and independent opticians, with its distribution network covering over 80 countries and reaching approximately 70,000 points of sale.

 

INSPECS has operations across the globe: with offices in the UK, Portugal, Scandinavia, the US and China (Hong Kong, Macau and Shenzhen), and manufacturing facilities in Vietnam, China, the UK and Italy. With the acquisition of Eschenbach, the Group's international reach further extends across Europe and the American markets.

 

More information is available at: https://inspecs.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUASKRUUUAOAR
Date   Source Headline
20th Oct 202211:12 amRNSHolding(s) in Company
19th Oct 20224:18 pmRNSHolding(s) in Company
15th Sep 20225:44 pmRNSHolding(s) in Company
7th Sep 20227:00 amRNSDirector/PDMR Share Dealing
30th Aug 20224:52 pmRNSHolding(s) in Company
23rd Aug 20225:02 pmRNSHolding(s) in Company
18th Aug 20227:00 amRNSInterim Results
11th Aug 20223:31 pmRNSResult of AGM
11th Jul 20221:19 pmRNSDirector/PDMR Shareholding
4th Jul 20227:00 amRNSDirector/PDMR Shareholding
1st Jul 20222:26 pmRNSDirector/PDMR Dealing
29th Jun 202212:37 pmRNSDirector/PDMR Shareholding
29th Jun 20227:00 amRNSFinal Results
24th Jun 20227:00 amRNSNotice of Final Results
7th Jun 20224:38 pmRNSHolding(s) in Company
31st May 202211:14 amRNSHolding(s) in Company
17th May 20225:41 pmRNSChange to Publication Date of Results
27th Apr 20227:00 amRNSQ1 Trading Update and Notice of Results
31st Mar 20224:17 pmRNSDirector/PDMR Share Dealing
18th Mar 202210:09 amRNSHolding(s) in Company
2nd Mar 20227:00 amRNSDirector/PDMR Share Dealing
1st Feb 20227:00 amRNSFull Year Trading Update
24th Jan 20227:00 amRNSHolding(s) in Company
11th Jan 20227:00 amRNSHolding(s) in Company
6th Jan 20227:00 amRNSAllotment of shares
24th Dec 20218:14 amRNSDirector/PDMR Share Dealing
23rd Dec 20217:00 amRNSAcquisition of Ego Eyewear
8th Dec 20217:00 amRNSAcquisition of BoDe
28th Oct 20217:00 amRNSQ3 Trading Update
20th Oct 20215:13 pmRNSHolding(s) in Company
8th Sep 20217:00 amRNSInterim Results
13th Aug 20217:00 amRNSNotice of Results
19th Jul 202111:42 amRNSResult of AGM
25th Jun 20217:00 amRNSAnnual Report and Notice of Annual General Meeting
21st Jun 20217:00 amRNSDirector/PDMR Dealing
18th Jun 20217:00 amRNSFinal Results
29th Apr 20217:00 amRNSQ1 Trading Update & Notice of Results
26th Feb 20217:00 amRNSDirector/PDMR LTIP Awards
8th Feb 20215:57 pmRNSHolding(s) in Company
29th Jan 20217:00 amRNSFull Year Trading Update
13th Jan 20218:25 amRNSHolding(s) in Company
23rd Dec 20204:21 pmRNSDirector/PDMR LTIP Awards
11th Dec 20201:05 pmRNSHolding(s) in Company
11th Dec 202012:00 pmRNSHolding(s) in Company
11th Dec 202011:58 amRNSDirector/PDMR Share Dealings
10th Dec 20203:11 pmRNSEschenbach Acquisition satisfaction of condition
7th Dec 20201:01 pmRNSResult of General Meeting
20th Nov 20207:00 amRNSPublication of Circular and Notice of GM
19th Nov 20202:05 pmRNSResult of Placing and Total Voting Rights
19th Nov 20207:00 amRNSProposed Placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.